Alico Price Target Raised to $42 by Roth Capital
Roth Capital maintained its "Buy" rating for Alico, Inc. (NASDAQ:ALCO) on November 26, 2025, and increased its price target from $35 to $42. This adjustment followed the company's Q4 2025 earnings call, which highlighted positive financial health and strategic direction.
The agribusiness company, specializing in citrus production and land management, was trading at $34.20 when Roth Capital affirmed its confidence in Alico's potential.
Alico conducted its Q4 2025 earnings call on November 25, 2025. Key participants included John Kiernan, President, CEO, and Director, and Bradley Heine, CFO and Accounting Officer. John Mills from ICR Inc. moderated the call, which provided insights into the company's performance and future plans.
As of current market data, ALCO's stock price is $33.88, marking a 1.80% increase, or $0.60. The stock has traded between a low of $33.49 and a high of $34.325 today. Over the past year, ALCO's stock has ranged from a high of $35.90 to a low of $24.76.
Alico's market capitalization is approximately $258.8 million, with a trading volume of 25,033 shares on the NASDAQ exchange. This market activity aligns with Roth Capital's optimistic outlook, suggesting continued investor interest in Alico's strategic trajectory.
Alico, Inc. (ALCO) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.